FDA Inspection 1191233 — Immunex Rhode Island Corporation
The FDA completed an inspection of Immunex Rhode Island Corporation on Oct 27, 2022 in West Greenwich, RI. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Oct 27, 2022
- Fiscal Year
- 2023
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- West Greenwich, RI (United States)